| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8436779 | Drug Resistance Updates | 2014 | 12 Pages |
Abstract
Low dose intensity, specific tumor-imaging techniques and potential biological biomarkers may be predictive for response to VEGF-targeted therapy in ccRCC. Some of these plausible biomarkers may also provide more insight into the underlying mechanisms of resistance such as altered glucose metabolism and rapid rebound vascularization.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Johannes C. van der Mijn, James W. Mier, Henk J. Broxterman, Henk M. Verheul,